col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


24 Results       Page 1

 [1] 
Elsevier: Molecular Immunology
  original article Date Title Authors   All Authors
1 [GO] 2025―Oct―08 Antibody preparation and immunological analysis of RBD from the SARS-CoV-2 Omicron BF.7 variant Quansheng Wang, Chenyi Wang, Zhicheng Zhang, Siyu Fan, Ping Lei, Shiguo Liu, et al. (+7)
2 [GO] 2025―Jan―25 Screening for immunodominant epitopes of SARS-CoV-2 based on CD8+ T cell responses from individuals with HLA-A homozygous alleles Rui He, Lingxin Meng, Yuting Sun, Jingsong Wang, Shufeng Wang, Yueping Liu, et al. (+6)
3 [GO] 2024―Dec―18 Recognizing SARS-CoV-2 infection of nasopharyngeal tissue at the single-cell level by machine learning method YuSheng Bao, QingLan Ma, Lei Chen, KaiYan Feng, Wei Guo, Tao Huang, Yu-Dong Cai
4 [GO] 2024―Sep―11 SARS-CoV-2 NSP14 induces AP-1 transcriptional activity via its interaction with MEK Weiling Li, Yuansong Wang, Qian Peng, Yingying Shi, Pin Wan, Yulin Yao, et al. (+5)
5 [GO] 2024―Feb―14 SARS-CoV-2 spike protein receptor binding domain promotes IL-6 and IL-8 release via ATP/P2Y2 and ERK1/2 signaling pathways in human bronchial epithelia Rui-Gang Zhang, Xing-Jian Liu, Yu-Ling Guo, Chun-Ling Chen
6 [GO] 2023―Sep―20 Longitudinal change trend of the TCR repertoire reveals the immune response intensity of the inactivated COVID-19 vaccine Chengsi Ren, Ruili Ji, Yizhe Li, Jinyong He, Wei Hu, Xiangyun Teng, et al. (+3)
7 [GO] 2023―Mar―10 Mechanistic Insight into the Protective and Pathogenic immune-responses against SARS-CoV-2 Prabhat K. Purbey, Koushik Roy, Sandeep Gupta, Manash K. Paul
8 [GO] 2023―Mar―10 Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: a review Maria da Conceição Rodrigues Fernandes, Germana Silva Vasconcelos, Amanda Campelo Lima de Melo, Tamires Cardoso Matsui, Ludmilla Freire Caetano, Fernanda Montenegro de Carvalho Araújo, Marcela Helena Gambim Fonseca
9 [GO] 2022―Nov―24 Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches Shahrzad Ahmadi, Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
10 [GO] 2022―Nov―03 Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients Ling Wang, Juan Zhao, Madison Schank, Sushant Khanal, Xindi Dang, Dechao Cao, et al. (+10)
11 [GO] 2022―Aug―22 Targeting thromboinflammation in COVID-19 - a narrative review of the potential of C1 inhibitor to prevent disease progression Pascal Urwyler, Stephan Moser, Marten Trendelenburg, Parham Sendi, Michael Osthoff
12 [GO] 2022―Jun―23 Preclinical Study of Formulated Recombinant Nucleocapsid protein, the Receptor Binding Domain of the Spike protein, and Truncated Spike (S1) Protein as Vaccine Candidates against COVID-19 in Animal Models Shahram Nazarian, Gholamreza Olad, Raziyeh Abdolhamidi, Mohammad Javad Motamedi, Rouhollah Kazemi, Emad Kordbacheh, et al. (+12)
13 [GO] 2022―May―23 Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model Emerson de Castro Barbosa, Adriana de Souza Andrade, Myrian Morato Duarte, Gilson Faria, Felipe Campos de Melo Iani, Ana Caroline Zampiroli Ataide, et al. (+4)
14 [GO] 2022―Mar―07 Use of sulforaphane in COVID-19: clinical trials are needed Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
15 [GO] 2022―Mar―04 Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood Josefine Persson, Björn Andersson, Suzanne van Veen, Mariëlle C. Haks, Ogonna Obudulu, Sara Torkzadeh, et al. (+5)
16 [GO] 2022―Jan―17 Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2 María Noel Badano, Florencia Sabbione, Irene Keitelman, Matias Pereson, Natalia Aloisi, Ana Colado, et al. (+9)
17 [GO] 2021―Dec―10 Generation and utility of a single-chain variable fragment monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein Reda Salem, Alaa A. El-Kholy, Fatma R. Waly, Dalia Ayman, Aya Sakr, Mai Hussein
18 [GO] 2021―Aug―06 Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression Ata Mahmoodpoor, Maryam Hosseini, Sadegh Soltani-Zangbar, Sarvin Sanaie, Leili Aghebati-Maleki, Seyed Hadi Saghaleini, et al. (+11)
19 [GO] 2021―Jun―30 Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement Mugdha Mohkhedkar, Siva Sai Krishna Venigalla, Vani Janakiraman
20 [GO] 2021―May―11 Functionally active cyclin-dependent kinase 9 is essential for porcine reproductive and respiratory syndrome virus subgenomic RNA synthesis Meng-Di Wang, Le Yang, Jie-Jie Meng, Jia-Jia Pan, Chao Zhang, Bo Wan, et al. (+4)
21 [GO] 2021―Apr―30 Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection Mumtaz Y. Balkhi
22 [GO] 2021―Mar―26 SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection Stefanos A. Tsiftsoglou
23 [GO] 2021―Jan―11 Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips Dan Liu, Feng Wu, Yu Cen, Lei Ye, Xueyin Shi, Yulan Huang, et al. (+2)
24 [GO] 2020―Oct―14 High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19 Jose J. Guirao, Carmen M. Cabrera, Natalia Jiménez, Laura Rincón, José M. Urra
 [1] 

24 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.009 sec